P/117/2010
Key facts
Active substance |
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/117/2010
|
PIP number |
P/117/2010
|
Pharmaceutical form(s) |
Modified release capsule
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Temmler Werke GmbH
E-mail: avril.mankel@ndareg.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|